Plasmodium falciparum liver-stage antigen-1 peptide-specific interferon-γ responses are not suppressed during uncomplicated malaria in African children

European Cytokine Network

Volumn 12, Issue 4, 2001, Pages 647-653

  Luty, Adrian J F ^a   Bongartz, Martina ^a   Rezbach, Philipp ^a   Faucher, Jean Francois ^a   Hollingdale, Michael R ^a   Kremsner, Peter G ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cytokine; Interferon ; Liver; Malaria

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; LIVER STAGE ANTIGEN 1; MALARIA VACCINE; UNCLASSIFIED DRUG;

ACUTE PHASE RESPONSE; AFRICA; AMINO TERMINAL SEQUENCE; ANTIGEN SPECIFICITY; ARTICLE; CHILD; CONTROLLED STUDY; CONVALESCENCE; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MALARIA FALCIPARUM; MONONUCLEAR CELL; NONHUMAN; PLASMODIUM FALCIPARUM; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, PROTOZOAN; CELL DIVISION; CHILD; CHILD, PRESCHOOL; EPITOPES; HUMANS; INFANT; INTERFERON TYPE II; MALARIA VACCINES; MALARIA, FALCIPARUM; MOLECULAR SEQUENCE DATA; MONOCYTES; PLASMODIUM FALCIPARUM;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0035680508     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Time to put malaria control on the global agenda
2. Perspectives on malaria vaccine development
3. Immunity to liver stages
4. Acquired immunity to asexual blood stages
5. Acquired immunity to sporozoites
6. The role of T cells in immunity to malaria
7. Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2 a recombinant Plasmodium falciparum malaria vaccine
8. Field studies of cytotoxic T lymphocytes in malaria infections: Implications for malaria vaccine development
9. Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants
10. A liver-stage-specific antigen of Plasmodium falciparum characterised by gene cloning
11. Structure of Plasmodium falciparum liver stage antigen-1
12. Pre-erythrocytic immunity to Plasmodium falciparum: The case for an LSA-1 vaccine
13. HLA-DQB1*0501-restricted Th1 type immune response to Plasmodium falciparum liver stage antigen 1 protect against malaria anemia and reinfections
14. Immune response to Plasmodium falciparum liver stage antigen-1: Geographical variations within Central Africa and their relationship with protection from clinical malaria
15. Biology of malarial liver stages: Implications for vaccine design
16. Sequence variations in the non-repetitive regions of the liver stage-specific antigen-1 (LSA-1) of Plasmodium falciparum from field isolates
17. Development of a malaria vaccine
18. T cell immunity to peptide epitopes of liver-stage antigen-1 in an area of Papua New Guinea in which malaria is holoendemic
19. Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon
20. Interferon-γ responses are associated with resistance to reinfection with Plasmodium falciparum in young African children
21. Cytokine responses to Plasmodium falciparum liver-stage antigen 1 vary in rainy and dry seasons in highland Kenya
22. Mosquito distribution and entomological inoculation rates in three malaria-endemic areas in Gabon
23. Malaria epidemiology in the province of Moyen Ogoov, Gabon
24. T lymphocytes from volunteers immunized with irradiated Plasmodium falciparum sporozoites recognize liver and blood stage malaria antigens
25. Immunologic responses to soluble exoantigens of Plasmodium falciparum in Gabonese children exposed to continuous intense infection
26. Analysis of immune responses against T and B cell epitopes from Plasmodium falciparum liver-stage antigen 1 in rodent malaria models and malaria-exposed human subjects in India
27. Interleukin-10 inhibts tumor necrosis factor production but not antigen-specific lymphoproliferation in acute Plasmodium falciparum malaria
28. Cellular immune responses to Plasmodium falciparum antigens in Gambian children during and after an acute attack of falciparum malaria
29. Influence of age and HLA type on interferon-gamma (IFN-gamma) responses to a naturally occurring polymorphic epitope of Plasmodium falciparum liver stage antigen-1 (LSA-1)
30. Degenerate cytotoxic T cell epitopes from Plasmodium falciparum restricted by multiple HLA-A and HLA-B supertype alleles
31. Kinetics of lymphocyte subsets from peripheral blood during a Plasmodium falciparum attack
32. Rapid reemergence of T cells into peripheral circulation following treatment of severe and uncomplicated Plasmodium falciparum malaria
33. Immune response in patients during and after Plasmodium falciparum infection
34. Non-CS pre-erythrocytic protective antigens
35. Immune effector mechanisms in malaria
36. - peripheral blood mononuclear cells in patients with Plasmodium falciparum malaria
37. + T cells in the Plasmodium yoelii model
38. Natural killer cell cytokine production, not cytotoxicity, contributes to resistance against blood-stage Plasmodium chabaudi AS infection
39. + TCR alpha beta intermediate cells increase during experimental malaria infection and are able to exhibit inhibitory activity against the parasite liver stage in vitro
40. Endogenous interleukin-10 modulates proinflammatory response in Plasmodium falciparum malaria
41. The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer
42. Low interleukin-12 activity in severe Plasmodium falciparum malaria